BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35026645)

  • 21. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircFAM64A enhances cellular processes in triple-negative breast cancer by targeting the miR-149-5p/CDT1 axis.
    Maimaiti Y; Zhang N; Zhang Y; Zhou J; Song H; Wang S
    Environ Toxicol; 2022 May; 37(5):1081-1092. PubMed ID: 35048507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells.
    Shuaib M; Kumar S
    Pathol Res Pract; 2024 Jan; 253():155017. PubMed ID: 38101160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
    Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
    Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F; Luo N; Hu Y; Li X; Zhang K
    Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
    Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
    Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
    Wang L; Kang FB; Wang J; Yang C; He DW
    Anticancer Drugs; 2019 Mar; 30(3):225-232. PubMed ID: 30334817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
    Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
    Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
    J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression.
    Kong Y; Yang L; Wei W; Lyu N; Zou Y; Gao G; Ou X; Xie X; Tang H
    Epigenomics; 2019 Aug; 11(10):1163-1176. PubMed ID: 31337246
    [No Abstract]   [Full Text] [Related]  

  • 35. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
    Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
    Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
    Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
    J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.
    Huang WC; Chi HC; Tung SL; Chen PM; Shih YC; Huang YC; Chu PY
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
    Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
    Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.